Brief: Jasper Therapeutics Appoints Herb Cross As Chief Financial Officer
Sept 25 (Reuters) - Jasper Therapeutics Inc JSPR.O :
* JASPER THERAPEUTICS APPOINTS HERB CROSS AS CHIEF FINANCIAL
OFFICER
* JASPER THERAPEUTICS INC - JEET MAHAL, PREVIOUSLY BOTH CFO
AND
CHIEF OPERATING OFFICER (COO), WILL CONTINUE AS COMPANY'S COO
* JASPER THERAPEUTICS INC: JEET MAHAL, WHO PREVIOUSLY HELD
BOTH
CFO AND CHIEF OPERATING OFFICER ROLES, WILL CONTINUE AS
COMPANY'S COO
Source text for Eikon: ID:nGNX4vRRcN
Further company coverage: JSPR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Jasper Therapeutics
See all newsBrief: Jasper Therapeutics Announces Commencement Of An Offer To Purchase Outstanding Warrants
Jasper Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Jasper Therapeutics Q2 loss per share beats estimates, raises $132 mln
Jasper Therapeutics, Inc. expected to post a loss of 35 cents a share - Earnings Preview
Jasper Therapeutics rises; co announces all-stock merger with Kira Pharma